<SEC-DOCUMENT>0001213900-23-014126-index.html : 20230224
<SEC-HEADER>0001213900-23-014126.hdr.sgml : 20230224
<ACCEPTANCE-DATETIME>20230224075525
ACCESSION NUMBER:		0001213900-23-014126
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230224
DATE AS OF CHANGE:		20230224

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NLS Pharmaceutics Ltd.
		CENTRAL INDEX KEY:			0001783036
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92065
		FILM NUMBER:		23662382

	BUSINESS ADDRESS:	
		STREET 1:		THE CIRCLE 6
		STREET 2:		8058
		CITY:			ZURICH
		STATE:			V8
		ZIP:			CH-6370
		BUSINESS PHONE:		41-41-618-80-00

	MAIL ADDRESS:	
		STREET 1:		THE CIRCLE 6
		STREET 2:		8058
		CITY:			ZURICH
		STATE:			V8
		ZIP:			CH-6370

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Grisard Felix
		CENTRAL INDEX KEY:			0001966808

	FILING VALUES:
		FORM TYPE:		SC 13G

	MAIL ADDRESS:	
		STREET 1:		C/O NLS PHARMACEUTICS LTD.
		STREET 2:		THE CIRCLE 6
		CITY:			ZURICH
		STATE:			V8
		ZIP:			8058
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>ea174177-13ggrisard_nlsphar.htm
<DESCRIPTION>SCHEDULE 13G
<TEXT>
Document 1 - file: ea174177-13ggrisard_nlsphar.htm

</DOCUMENT>
</SEC-DOCUMENT>